Preliminary analyses indicate that the efficacy of Sgc8c-M appears to depend on PTK7 expression levels in different tumor models of the same cancer type, including TNBC, pancreatic cancer, and NSCLC (Supplementary Table 7 and Supplementary Fig. 25). This evidence concerns the gene PTK7 and cancer.